Unlike the rats favoured as animal models for many other diseases, dogs develop haemophilia naturally, have enough blood to contribute to research studies and live long enough to reveal long-term outcomes of treatments. "We have a 60-year track record now showing that if it works well in dogs, it's likely going to work well in humans," says Nichols.